Bentiromide

CHEMBL1200368 Phase 4 अनुमोदित Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
404.4 g/mol
LogP
3.3
Phase
4

A peptide used as a diagnostic test for exocrine pancreatic function; after oral ingestion, pancreatic chymotrypsin cleaves the peptide to release para-aminobenzoic acid, which is measured in urine. It is not used as a therapeutic agent.

आणविक भार

404.4000 g/mol

LogP

3.30

TPSA

116.00 Ų

लिपिंस्की RO5

उत्तीर्ण

क्रिया का तंत्र

Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

तंत्र

Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.

2D संरचना

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

O=C(O)c1ccc(NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)c2ccccc2)cc1

InChI

InChI=1S/C23H20N2O5/c26-19-12-6-15(7-13-19)14-20(25-21(27)16-4-2-1-3-5-16)22(28)24-18-10-8-17(9-11-18)23(29)30/h1-13,20,26H,14H2,(H,24,28)(H,25,27)(H,29,30)/t20-/m0/s1

Molecular Formula

C23H20N2O5

HBD / HBA

4 / 5

घूर्णनीय बंधन

7

भारी परमाणु

30

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

अक्सर पूछे जाने वाले प्रश्न

A peptide used as a diagnostic test for exocrine pancreatic function; after oral ingestion, pancreatic chymotrypsin cleaves the peptide to release para-aminobenzoic acid, which is measured in urine. It is not used as a therapeutic agent.

Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.

Yes, Bentiromide is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200368. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 6957673. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

चिकित्सा अस्वीकरण

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.